Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

VTB's SPO application Book has been oversubscribed

17:01 VTBR

Trading in Ozon securities will be suspended from September 23

14:36 OZON

Rusal develops aluminum construction materials

13:01 RUAL

Henderson's revenue in August increased by 21%

12:44 HNFG

Yandex acquired a minority stake in Diagnostics at Home

11:07 YDEX

X5 is testing a new format of ultra-small stores On the Fly!

10:41 X5

Samolet sold part of the Rublevsky Quarters project

10:34 SMLT

Bank Saint Petersburg reported on RAS for August

10:25 BSPB

VTB will place an additional issue for no more than 73.9 ₽ per share

10:18 VTBR

Yandex is robotizing the Crossroads distribution center

09:01 YDEX